Jordi Rimola MD, Presenter: Consultant, Robarts Clinical Trials Research Group

Tomas Ripolles MD, Abstract Co-Author: Nothing to Disclose

Sonia Rodriguez MD, Abstract Co-Author: Nothing to Disclose

Miriam Cuatrecasas, Abstract Co-Author: Nothing to Disclose

Ingrid Ordas, Abstract Co-Author: Nothing to Disclose

Julian Panes, Abstract Co-Author: Nothing to Disclose

1. To discuss the relevance of monitoring Crohn’s disease by imaging modalities. 2. To become familiar with useful radiological signs after medical treatment of Crohn’s disease. 3. To understand the changes which occur after recurrence in Crohn’s disease.  

A) What techniques are available for monitoring Crohn’s disease (CD) and what are the pros and cons of each: - Clinical symptoms - Biomarkers (CRP, calprotectin,..) - Endoscopy - Cross-sectional imaging B) What are the gains and possibilities of monitoring CD by cross sectional imaging C) What is known and what are the limitations of cross-sectional imaging for monitoring CD D) Providing representative examples including US, CTE and MRE with correlation to endoscopic and/or pathological findings. Knowing the changes of the lesions after treatment could be used to confirm the disease activity state and to improve patient management E) Future trends and directions Preliminary evidence suggests that in CD a state of remission beyond the simple control of clinical symptoms, and including healing of lesions, may be associated with better disease outcome. Monitoring the disease through the use of cross-sectional imaging is gaining increased acceptance as it has advantages over endoscopy, but also limitations that should be made aware.

http://abstract.rsna.org/uploads/2014/14012659/14012659_pbdn.pdf

Rimola, J, Ripolles, T, Rodriguez, S, Cuatrecasas, M, Ordas, I, Panes, J, Monitoring Crohn's Disease with Cross Sectional Imaging: Still A Lot of Room to Grow.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14012659.html